QT prolongation with hydroxychloroquine and azithromycin for the treatment of COVID-19: The need for pharmacogenetic insights

被引:2
作者
Lopez-Medina, Ana I. [1 ]
Campos-Staffico, Alessandra M. [1 ]
Luzum, Jasmine A. [1 ]
机构
[1] Univ Michigan, Coll Pharm, Dept Clin Pharm, 428 Church St, Ann Arbor, MI 48109 USA
关键词
arrhythmia; azithromycin; COVID-19; hydroxychloroquine; ion channels; pharmacogenetics; polymorphism; QT prolongation;
D O I
10.1111/jce.14722
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2793 / 2794
页数:2
相关论文
共 50 条
[41]   Effect of Hydroxychloroquine and Azithromycin Combination Use in COVID-19 Patients - An Umbrella Review [J].
Nag, Kaushik ;
Tripura, Kaushik ;
Datta, Anjan ;
Karmakar, Nabarun ;
Singh, Manvi ;
Singh, Meenu ;
Singal, Kusum ;
Pradhan, Pranita .
INDIAN JOURNAL OF COMMUNITY MEDICINE, 2024, 49 (01) :22-27
[42]   Hydroxychloroquine and azithromycin use in COVID-19 era and cardiovascular concerns: Current perspective [J].
Kapoor, Aditya ;
Sahu, Ankit Kumar .
JOURNAL OF THE PRACTICE OF CARDIOVASCULAR SCIENCES, 2021, 7 (01) :78-82
[43]   Hydroxychloroquine and Azithromycin Combination in the Management of COVID-19 Infection: Safety and Effectiveness Challenges [J].
Abou Warda, Ahmed E. ;
Tammam, Mahmoud ;
El-Gazar, Rabab A. ;
Sarhan, Rania M. ;
Gaber, Sayed .
CURRENT DRUG SAFETY, 2022, 17 (02) :143-151
[44]   Combination of hydroxychloroquine and azithromycin as a treatment of Covid-19. Results of an observational study including 80 Covid-19 patients [J].
Malmartel, Alexandre ;
Jouannin, Adeline ;
Pouchain, Denis .
EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2020, (163) :221-223
[45]   Outcomes after early treatment with hydroxychloroquine and azithromycin: An analysis of a database of 30,423 COVID-19 patients [J].
Brouqui, Philippe ;
Million, Matthieu ;
Parola, Philippe ;
Mccullough, Peter A. ;
Raoult, Didier .
NEW MICROBES AND NEW INFECTIONS, 2023, 55
[46]   The use of Hydroxychloroquine in the Treatment of COVID-19 [J].
Tecen-Yucel, Kamer ;
Kara, Emre ;
Demirkan, Kutay ;
Unal, Serhat .
FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2020, 25 (03) :283-291
[47]   Will Hydroxychloroquine Still Be a Game-Changer for COVID-19 by Combining Azithromycin? [J].
Li, Chunfeng ;
Cheng, Genhong .
FRONTIERS IN IMMUNOLOGY, 2020, 11
[48]   Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity [J].
Hache, Guillaume ;
Rolain, Jean Marc ;
Gautret, Philippe ;
Deharo, Jean-Claude ;
Brouqui, Philippe ;
Raoult, Didier ;
Honore, Stephane .
MICROBIAL DRUG RESISTANCE, 2021, 27 (03) :281-290
[49]   Does Combining Severe and Mild Cases of COVID-19 Produce Low Fatality Rates After Treatment With Hydroxychloroquine and Azithromycin? [J].
Fleury, Vincent .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2020, 189 (11) :1227-1229
[50]   Response to the editorial "COVID-19 in patients with cardiovascular diseases". Covid-19 treatment with hydroxychloroquine or chloroquine and azithromycin: A potential risk of Torsades de Pointes [J].
Funck-Brentano, Christian ;
Salem, Joe-Elie ;
Nguyen, Lee S. ;
Drici, Milou-Daniel ;
Roden, Dan M. .
ARCHIVES OF CARDIOVASCULAR DISEASES, 2020, 113 (05) :367-368